Synthetic ghrelin
合成生长素
Report date: 2022/11/24 20:00:41
Base Information
Drug NameSynthetic ghrelin
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[6]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California San DiegoBiopharma Forest
China Registration ClassN/A
Develop Information
Active CompaniesOxeia Biopharmaceuticals IncThe University Of Kansas Medical CenterUniversity of Kansas Health System
Inactive CompaniesDaiichi Sankyo Co Ltd
Active Indications
Inactive Indications